BUFFALO GROVE, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ: AKRX) today announced the appointment of Shawn L. Silvestri, Ph.D. as Vice President, New Product Development. Dr. Silvestri brings fifteen years experience in pharmaceutical research and development with Abbott Laboratories, Abbott Park, IL to his new role at Akorn.
